Picture of Minerva Neurosciences logo

NERV — Minerva Neurosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Minerva Neurosciences Inc expected to post a loss of $1.32 a share - Earnings Preview

* Minerva Neurosciences Inc  NERV.OQ   NERV.O  is expected
to show
no change in quarterly revenue when it reports  results on
November 9. 
    * 
    * ​Refinitiv's mean analyst estimate for Minerva
Neurosciences Inc
is for a loss of $1.32 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Minerva
Neurosciences Inc is $8​, above​ its last closing price
of $2.55. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -1.66       -1.65      -1.63     Beat    1.4
 Mar. 31 2022  -1.43       -1.48      -1.84     Missed  -24.3
 Dec. 31 2021  -1.52       -1.50      -4.00     Missed  -166.7
                                                        ​
 Sep. 30 2021  -1.89       -1.76      -1.76     Met     0
 ​​Jun.        -1.42       -1.39      -2.00     Missed  -43.7
 30 2021                                                
 Mar. 31 2021  -0.32       2.66       -1.44     Missed  -154.2
                                                        ​
 Dec. 31 2020  -1.40       -1.53      -1.44     Beat    6.1
 Sep. 30 2020  -1.85       -1.85      -1.52     Beat    17.6
 This summary was machine generated November 7 at 19:40 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Minerva Neurosciences

See all news